|Podcasts|March 4, 2022

Enhancing Conversational AI

Author(s)Nicholas Saraceno, Senior Editor, Julian Upton

Tech platform aims to dispel chatbot stereotypes

Patty Riskind, CEO of Orbita, discusses the origins of the platform, her inspiration in joining the team, how in fact the company uses conversational artificial intelligence (AI) to its advantage and the future outlook of this technology.

The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Related Content

Pharma Pulse

Pharma Pulse: DHL's New Singapore Hub and Pharma Rethinks Go-To Market

ByStephen Appezzato

September 10th 2026

Pharma Pulse

Pharma Pulse: MFN Expansion, GoodRx's Family Plan, CSafe's Reusable Cover

ByStephen Appezzato

September 4th 2026

Pharma Pulse

Pharma Pulse: Medicaid Deals, GLP-1 Pullback, McKesson's Buy

ByStephen Appezzato

August 27th 2026

Pharma Pulse

Pharma Pulse: Overton's FDA Bid, EVERSANA's AI Expansion, and a Landmark Cancer Vaccine

ByStephen Appezzato

August 20th 2026

Pharma Pulse: Retatrutide's Black Market Problem, CSafe's Mobile App, BMS's Houston Bet

ByStephen Appezzato

August 13th 2026

Trending on Pharmaceutical Commerce

Why Pharma's Next AI Challenge Is Supervision, Not Adoption

FAQ: Inside the Latest MFN Deals Signed by Nine Drugmakers

Gregg Gorniak: What Changed in Five Years of DSCSA?

Using AI to Manage GDP-Compliant Supply Chains

How Rising Cargo Theft Puts New Pressure on the Pharma Supply Chain